Literature DB >> 8234624

Neuropsychological prediction of treatment efficacy and one-year outcome in schizophrenia.

R S Goldman1, B N Axelrod, R Tandon, S C Ribeiro, K Craig, S Berent.   

Abstract

The present study was conducted to establish the degree of interrelationship between neuropsychological functioning in the acute phase of the schizophrenic illness, clinical measures of treatment response (positive and negative symptoms), and 1-year outcome. Nineteen SADS/RDC schizophrenic inpatients were clinically rated during a 2-week drug washout period and again following 4 weeks of neuroleptic treatment. The findings revealed that reduced attentional ability in the baseline phase significantly predicted the presence of higher residual negative symptoms following 4 weeks of treatment, while neurocognitive status was unrelated to positive symptom response. With respect to prediction of the 1-year outcome, poor functional status of this schizophrenic population was significantly associated with the presence of baseline memory dysfunction.

Entities:  

Mesh:

Year:  1993        PMID: 8234624     DOI: 10.1159/000284811

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  7 in total

1.  Cognitive effects of olanzapine treatment in schizophrenia.

Authors:  Susan R McGurk; M A Lee; K Jayathilake; Herbert Y Meltzer
Journal:  MedGenMed       Date:  2004-05-10

2.  Risperidone nonadherence and return of positive symptoms in the early course of schizophrenia.

Authors:  Kenneth L Subotnik; Keith H Nuechterlein; Joseph Ventura; Michael J Gitlin; Stephen Marder; Jim Mintz; Gerhard S Hellemann; Leslie A Thornton; Indira R Singh
Journal:  Am J Psychiatry       Date:  2011-01-04       Impact factor: 18.112

Review 3.  Cognitive control deficits in schizophrenia: mechanisms and meaning.

Authors:  Tyler A Lesh; Tara A Niendam; Michael J Minzenberg; Cameron S Carter
Journal:  Neuropsychopharmacology       Date:  2010-09-15       Impact factor: 7.853

4.  Auditory memory decrements, without dissimulation, among patients with major depressive disorder.

Authors:  Ciaran M Considine; Sara L Weisenbach; Sara J Walker; E Michelle McFadden; Lindsay M Franti; Linas A Bieliauskas; Daniel F Maixner; Bruno Giordani; Stanley Berent; Scott A Langenecker
Journal:  Arch Clin Neuropsychol       Date:  2011-05-18       Impact factor: 2.813

5.  The Relationship Between the Recognition of Basic Emotions and Negative Symptoms in Individuals With Schizophrenia Spectrum Disorders - An Exploratory Study.

Authors:  Marco Zierhut; Kerem Böge; Niklas Bergmann; Inge Hahne; Alice Braun; Julia Kraft; Thi Minh Tam Ta; Stephan Ripke; Malek Bajbouj; Eric Hahn
Journal:  Front Psychiatry       Date:  2022-04-27       Impact factor: 5.435

Review 6.  Effect of second-generation antipsychotics on employment and productivity in individuals with schizophrenia: an economic perspective.

Authors:  Mauro Percudani; Corrado Barbui; Michele Tansella
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

7.  Relationship of cognitive function in patients with schizophrenia in remission to disability: a cross-sectional study in an Indian sample.

Authors:  Rajeev Krishnadas; Brian P Moore; Ajita Nayak; Ramesh R Patel
Journal:  Ann Gen Psychiatry       Date:  2007-07-30       Impact factor: 3.455

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.